Business Description
Aptose Biosciences Inc
NAICS : 325412
SIC : 3741
ISIN : CA03835T2002
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 9.11 | |||||
Equity-to-Asset | -0.22 | |||||
Debt-to-Equity | -0.35 | |||||
Debt-to-EBITDA | -0.02 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 7.3 | |||||
3-Year EPS without NRI Growth Rate | 7.6 | |||||
3-Year FCF Growth Rate | -3.6 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 18.74 | |||||
9-Day RSI | 25.31 | |||||
14-Day RSI | 29.94 | |||||
6-1 Month Momentum % | -41.13 | |||||
12-1 Month Momentum % | -78.89 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.78 | |||||
Quick Ratio | 0.78 | |||||
Cash Ratio | 0.61 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.3 | |||||
Shareholder Yield % | -38.24 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -308.69 | |||||
ROA % | -169.05 | |||||
ROIC % | -3128.16 | |||||
ROC (Joel Greenblatt) % | -4003.46 | |||||
ROCE % | -300.81 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.21 | |||||
EV-to-Forward-EBIT | -0.24 | |||||
EV-to-EBITDA | -0.21 | |||||
EV-to-Forward-EBITDA | -0.24 | |||||
EV-to-FCF | -0.25 | |||||
Earnings Yield (Greenblatt) % | -476.19 | |||||
FCF Yield % | -230.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Aptose Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | |||
EPS (TTM) (C$) | -10.408 | ||
Beta | 1.13 | ||
Volatility % | 73.41 | ||
14-Day RSI | 29.94 | ||
14-Day ATR (C$) | 0.109316 | ||
20-Day SMA (C$) | 1.884 | ||
12-1 Month Momentum % | -78.89 | ||
52-Week Range (C$) | 1.65 - 11.399999 | ||
Shares Outstanding (Mil) | 15.72 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Aptose Biosciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Aptose Biosciences Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Aptose Biosciences Inc Frequently Asked Questions
What is Aptose Biosciences Inc(TSX:APS)'s stock price today?
When is next earnings date of Aptose Biosciences Inc(TSX:APS)?
Does Aptose Biosciences Inc(TSX:APS) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |